Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patients
出版年份 2014 全文链接
标题
Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patients
作者
关键词
-
出版物
Future Oncology
Volume 10, Issue 8, Pages 1353-1360
出版商
Future Medicine Ltd
发表日期
2014-07-23
DOI
10.2217/fon.14.71
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
- (2013) A. M. Aparicio et al. CLINICAL CANCER RESEARCH
- Re: Abiraterone in Metastatic Prostate Cancer Without Previous Chemotherapy
- (2013) Giuseppe Di Lorenzo et al. EUROPEAN UROLOGY
- Poor Survival in Prostate Cancer Patients with Primary Refractoriness to Docetaxel
- (2013) Giuseppe Di Lorenzo et al. EUROPEAN UROLOGY
- New Perspectives in the Therapy of Castration Resistant Prostate Cancer
- (2012) Pasquale Rescigno et al. CURRENT DRUG TARGETS
- Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
- (2012) Himisha Beltran et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- (2012) David C. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
- (2011) A. Flechon et al. ANNALS OF ONCOLOGY
- Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients
- (2011) Carlo Buonerba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Immunotherapy for the treatment of prostate cancer
- (2011) Giuseppe Di Lorenzo et al. Nature Reviews Clinical Oncology
- Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer
- (2010) Giuseppe Di Lorenzo et al. BJU INTERNATIONAL
- Castration-Resistant Prostate Cancer
- (2010) Giuseppe Di Lorenzo et al. DRUGS
- Docetaxel Rechallenge in Castration-Resistant Prostate Cancer: Scientific Legitimacy of Common Clinical Practice
- (2010) Carlo Buonerba et al. EUROPEAN UROLOGY
- Sipuleucel-T for prostate cancer: the immunotherapy era has commenced
- (2010) Carlo Buonerba et al. Expert Review of Anticancer Therapy
- Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features
- (2009) Y. Loriot et al. ANNALS OF ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started